GRIN2A missense mutation retained sensitivity to memantine, and memantine test results showed a significant reduction in seizure frequency. The patients with GRIN2B mutation-related encephalopathy treated with memantine had improved consciousness, behavior and sleep, but none showed a reduction in seizure frequency. This evidence concerns the gene GRIN2B and Encephalopathy.